Literature DB >> 21208659

Estrogenic and androgenic activities in total plasma measured with reporter-gene bioassays: relevant exposure measures for endocrine disruptors in epidemiologic studies?

Marijn M Brouwers1, Harrie Besselink, Reini W Bretveld, Rob Anzion, Paul T J Scheepers, Abraham Brouwer, Nel Roeleveld.   

Abstract

Measurements of estrogenic and androgenic activities in total plasma with Chemically Activated LUciferase gene eXpression (CALUX®) bioassays could provide biologically relevant measures for exposure to endocrine disruptors in epidemiologic studies. The objective of this study was to explore the effects of a variety of sources of potential endocrine disruptors on estrogenic and androgenic activities in total plasma measured by CALUX®. Plasma samples and interview data on sources of potential endocrine disruptors were collected from 108 men with different exposures profiles. CALUX® measurements (BioDetection Services) involved human U2-OS cell lines controlled by the estrogen receptor alpha and the androgen receptor. Mean differences (beta) in 17β-estradiol equivalents (EEQs) and dihydrotestosterone equivalents (AEQs) between exposure groups were estimated using general linear models. Mean plasma AEQs and EEQs were 9.1×10(-1)ng/ml and 12.0pg/ml, respectively. Elevated AEQs were found in smokers (beta 1.9 (95%CI 0.1-3.6)×10(-1)ng/ml) and heavy drinkers (1.4 (0.2-3.1)×10(-1)ng/ml), and in men occupationally exposed to disinfectants (1.6 (0.3-3.5)×10(-1)ng/ml) or welding/soldering fumes (1.4 (-0.2-2.9)×10(-1)ng/ml). Occupational exposure to pesticides, disinfectants, and exhaust fumes seemed to be associated with increased plasma EEQs: 1.5 (-0.2-3.2)pg/ml, 2.1 (0.2-3.9)pg/ml, and 2.9 (0.6-5.2)pg/ml, respectively. Moderate to high plasma dioxin levels, measured in a subgroup by the dioxin-responsive CALUX®, were accompanied by a 20% increase in AEQs. This is the first study in which CALUX® was used to assess hormone activities in total plasma. Although the results are not yet readily interpretable, they indicate that these measurements can be valuable for epidemiologic studies on endocrine disruptors and give direction for further research.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208659     DOI: 10.1016/j.envint.2010.11.001

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  5 in total

1.  Association of lifestyle and demographic factors with estrogenic and glucocorticogenic activity in Mexican American women.

Authors:  L Fejerman; S S Sanchez; R Thomas; P Tachachartvanich; J Riby; S L Gomez; E M John; M T Smith
Journal:  Carcinogenesis       Date:  2016-07-13       Impact factor: 4.944

2.  Assessment of the Endocrine-Disrupting Effects of Trichloroethylene and Its Metabolites Using in Vitro and in Silico Approaches.

Authors:  Phum Tachachartvanich; Rapeepat Sangsuwan; Heather S Ruiz; Sylvia S Sanchez; Kathleen A Durkin; Luoping Zhang; Martyn T Smith
Journal:  Environ Sci Technol       Date:  2018-01-19       Impact factor: 9.028

3.  Characterization, specificity and sensibility of produced anti-Rhamdia quelen vitellogenin in Brazilian fish species.

Authors:  Daniele Dietrich Moura Costa; Dandie Antunes Bozza; Luiz Eduardo Rizzo; Juan Garcia; Michele Dietrich Moura Costa; Ciro Alberto de Oliveira Ribeiro
Journal:  Fish Physiol Biochem       Date:  2016-06-18       Impact factor: 2.794

4.  Plasma glucocorticogenic activity, race/ethnicity and alcohol intake among San Francisco Bay Area women.

Authors:  Phum Tachachartvanich; Sylvia S Sanchez; Scarlett L Gomez; Esther M John; Martyn T Smith; Laura Fejerman
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

Review 5.  The Importance of the Biological Impact of Exposure to the Concept of the Exposome.

Authors:  Kristine K Dennis; Scott S Auerbach; David M Balshaw; Yuxia Cui; Margaret Daniele Fallin; Martyn T Smith; Avrum Spira; Susan Sumner; Gary W Miller
Journal:  Environ Health Perspect       Date:  2016-06-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.